Form 8-K - Current report:
SEC Accession No. 0000950170-21-000624
Filing Date
2021-07-30
Accepted
2021-07-30 16:08:51
Documents
12
Period of Report
2021-07-29
Items
Item 1.02: Termination of a Material Definitive Agreement

Document Format Files

Seq Description Document Type Size
1 8-K acet-20210729.htm   iXBRL 8-K 45509
  Complete submission text file 0000950170-21-000624.txt   174521

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT acet-20210729_pre.xml EX-101.PRE 11654
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT acet-20210729.xsd EX-101.SCH 2449
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT acet-20210729_lab.xml EX-101.LAB 19266
5 EXTRACTED XBRL INSTANCE DOCUMENT acet-20210729_htm.xml XML 4887
Mailing Address 200 CLARENDON STREET FLOOR 6 BOSTON MA 02116
Business Address 200 CLARENDON STREET FLOOR 6 BOSTON MA 02116 617-482-2333
Adicet Bio, Inc. (Filer) CIK: 0001720580 (see all company filings)

EIN.: 813305277 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38359 | Film No.: 211132616
SIC: 2834 Pharmaceutical Preparations